Cellectis SA ADR buy Quitte
Start price
29.02.16
/
50%
€21.07
Target price
18.03.16
€24.35
Performance (%)
15.63%
End price
18.03.16
€24.36
Summary
This prediction ended on 18.03.16 with a price of €24.36. The prediction had a final performance of 15.63%. Quitte has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cellectis SA ADR | -11.351% | -11.351% | 129.371% | 26.154% |
| iShares Core DAX® | -1.432% | 0.000% | 12.331% | 59.631% |
| iShares Nasdaq 100 | -0.386% | -0.595% | 4.688% | 98.396% |
| iShares Nikkei 225® | 1.448% | 5.269% | 18.051% | 50.544% |
| iShares S&P 500 | 0.114% | -0.217% | 1.388% | 63.586% |
Comments by Quitte for this prediction
In the thread Cellectis SA ADR diskutieren
gutes Rating und eventuell ein Boden
Shares of Cellectis SA (NASDAQ:CLLS) have received a consensus broker rating score of 1.00 (Strong Buy) from the four brokers that provide coverage for the stock, Zacks Investment Research reports. Four analysts have rated the stock with a strong buy recommendation.
(Zielkurs erreicht)

